Concentric Capital Strategies, LP Royalty Pharma PLC Transaction History
Concentric Capital Strategies, LP
- $1.94 Billion
- Q2 2024
A detailed history of Concentric Capital Strategies, LP transactions in Royalty Pharma PLC stock. As of the latest transaction made, Concentric Capital Strategies, LP holds 100,968 shares of RPRX stock, worth $2.74 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
100,968Holding current value
$2.74 Million% of portfolio
0.14%Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
406Shares Held
290MCall Options Held
305KPut Options Held
138K-
Morgan Stanley New York, NY44.1MShares$1.2 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA38MShares$1.03 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$624 Million0.01% of portfolio
-
Baillie Gifford & CO16.4MShares$443 Million0.34% of portfolio
-
Viking Global Investors LP12MShares$324 Million1.26% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $11.8B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...